Very timely to the region - "The ageing of the world's population is rapidly growing primarily due to an increase in life expectancy as well as to declining fertility rates. The 2016 Population Data Sheet by United Nations ESCAP disclosed that approximately 16% (1.3 billion) of the population in the Asia-Pacific Region would be 60 years or older by 2050. All countries, including those in Asia, are facing significant challenges (social, economic and political) with this rapid demographic transition characterized by reductions in infectious and acute diseases overshadowed by the rapid emergence of non-communicable and degenerative diseases."

Very timely to the region - "The ageing of the world's population is rapidly growing primarily due to an increase in life expectancy as well as to declining fertility rates. The 2016 Population Data Sheet by United Nations ESCAP disclosed that approximately 16% (1.3 billion) of the population in the Asia-Pacific Region would be 60 years or older by 2050. All countries, including those in Asia, are facing significant challenges (social, economic and political) with this rapid demographic transition characterized by reductions in infectious and acute diseases overshadowed by the rapid emergence of non-communicable and degenerative diseases."

Malaria is an increasing worldwide threat, with more than three hundred million infections and one million deaths every year. The world's poorest are the worst affected, and many treat themselves with traditional herbal medicines. These are often more available and affordable, and sometimes are perceived as more effective than conventional antimalarial drugs. The first book to be published on this subject, Traditional Medicinal Plants and Malaria explores the evidence for the safety and efficacy of some of these traditional medicines, and presents practical guidelines for designing studies on traditional plant-based antimalarial medicines, mosquito repellents, and insecticides. Systematic reviews of the literature and consensus guidelines form the main body of the book. Ethnomedical, ethnobotanical, pharmacological, phytochemical, toxicological, and clinical aspects of herbal antimalarials are also reviewed. These are supplemented by case studies of the most well-known traditional antimalarials.

Malaria is an increasing worldwide threat, with more than three hundred million infections and one million deaths every year. The world's poorest are the worst affected, and many treat themselves with traditional herbal medicines. These are often more available and affordable, and sometimes are perceived as more effective than conventional antimalarial drugs.

The first book to be published on this subject, Traditional Medicinal Plants and Malaria explores the evidence for the safety and efficacy of some of these traditional medicines, and presents practical guidelines for designing studies on traditional plant-based antimalarial medicines, mosquito repellents, and insecticides. Systematic reviews of the literature and consensus guidelines form the main body of the book. Ethnomedical, ethnobotanical, pharmacological, phytochemical, toxicological, and clinical aspects of herbal antimalarials are also reviewed. These are supplemented by case studies of the most well-known traditional antimalarials.

This is the first book to address public health issues in traditional, complementary and alternative medicine (TCAM). It presents state-of-the-art reviews of TCAM research in a range of priority public health areas such as malaria and HIV and in such common ailments as skin conditions and orthopedic injury in developing countries. Contributions analyze policy trends in areas such as financing of TCAM and education and training in this field as well as selected case studies of model TCAM projects. Important chapters on research methodology, ethical and safety issues, and intellectual property rights pertaining to traditional medicine are also presented.Public financing for TCAM is a test of the commitment of governments, and the book includes an analysis from the World Health Organization's (WHO) Global Atlas data of the worldwide trends in this area. With safety concerns foremost in the minds of both policy makers and the public, the book offers a global overview of policy and legislative trends in this field as well as an important set of guidelines for pharmacovigilance and TCAM products.

This publication discusses how carbon pricing instruments can be designed to help achieve net-zero greenhouse gas (GHG) emission targets while enabling economic recovery from the coronavirus disease (COVID-19) pandemic. Carbon pricing is a key element of the broader climate policy architecture that can help countries reduce GHG emissions cost-effectively, while mobilizing fiscal resources to foster green recovery and growth. The publication introduces carbon pricing instruments that can help countries design and implement an efficient climate change response. It also underscores the important role of carbon pricing in achieving nationally determined contributions and developing road maps for longer-term net-zero GHG emission targets.